Related Experiment Videos
Systemic inflammatory complications following jejuno-ileal bypass
The Quarterly Journal of Medicine
|January 1, 1982
Summary
Systemic inflammatory complications after jejuno-ileal bypass surgery, resembling Behçet's syndrome, were observed. Dapsone achieved remission, suggesting bacteria may initiate but not sustain these inflammatory issues.
Area of Science:
- Rheumatology
- Gastroenterology
- Infectious Diseases
Background:
- Jejuno-ileal bypass surgery for morbid obesity can lead to systemic inflammatory complications.
- These complications can mimic autoimmune or autoinflammatory conditions like Behçet's syndrome.
Observation:
- Three patients presented with a distinct set of symptoms including polyarthritis, tenosynovitis, skin pustules, mucous membrane ulceration, and retinal vasculitis post-surgery.
- While circulating immune complexes were not consistently detected, transient hypocomplementaemia and elevated inflammatory markers were noted before relapses.
Findings:
- Antibiotic therapy was ineffective in managing these inflammatory complications.
- Dapsone treatment resulted in sustained remission of symptoms in the affected patients.
- Bacterial overgrowth was not a universal finding, and symptom recurrence after bypass reversal suggested a complex etiology.
Implications:
- The findings suggest that bacteria might trigger, rather than continuously drive, the inflammatory process.
- Dapsone appears to be a promising therapeutic option for managing these post-surgical inflammatory syndromes.
- Further research is needed to elucidate the precise mechanisms linking jejuno-ileal bypass surgery to these systemic inflammatory conditions.